HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wennerås, C. Articles by Sansonetti, P. Search for Related Content PubMed PubMed Citation Articles by Wennerås, C. Articles by Sansonetti, P.

Blockade of CD14 Increases Shigella-Mediated Invasion and Tissue Destruction¹

Christine Wennerås^2,*,, Patrick Ave, Michel Huerre, Josette Arondel^*, Richard J. Ulevitch^§, John C. Mathison^§ and Philippe Sansonetti^*

^* Unité de Pathogénie Microbienne Moléculaire, Institut National de la Santé et de la Recherche Médicale, Unité 389, Institut Pasteur, Paris, France; Department of Medical Microbiology and Immunology, Göteborg University, Göteborg, Sweden; Unité d’Histopathologie, Institut Pasteur, Paris, France; and ^§ Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

Shigella is a diarrheal pathogen that causes disease through invasion of the large intestinal mucosa. The endotoxin of the invading bacterium may play a key role in the disease process by causing inflammation and tissue injury during infection. Earlier studies have shown that various animal species lacking functional CD14 were protected against endotoxin-mediated shock. Rabbits experimentally infected with Shigella were used to test the hypothesis that blockade of endotoxin-induced cell activation with anti-CD14 mAb would diminish inflammation and thus disease severity. Unexpectedly, we observed that the intestinal mucosa of anti-CD14-treated animals exhibited a 50-fold increase in bacterial invasion and more severe tissue injury compared with controls. Despite higher bacterial loads in treated animals, the numbers of polymorphonuclear leukocytes that were recruited to the infection site were similar to those in controls. Furthermore, the phagocytic cells of CD14-blocked animals produced IL-1 and TNF-. Moreover, in vitro blockade of CD14 did not impede bactericidal activity. Thus, anti-CD14 treatment interfered with host defense mechanisms involved with removal/eradication of Shigella.

This article has been cited by other articles:

				M.-I. Fernandez, B. Regnault, C. Mulet, M. Tanguy, P. Jay, P. J. Sansonetti, and T. Pedron Maturation of Paneth Cells Induces the Refractory State of Newborn Mice to Shigella Infection J. Immunol., April 1, 2008; 180(7): 4924 - 4930. [Abstract] [Full Text] [PDF]

				M. F. de Buhr, M. Mahler, R. Geffers, W. Hansen, A. M. Westendorf, J. Lauber, J. Buer, B. Schlegelberger, H. J. Hedrich, and A. Bleich Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics, May 16, 2006; 25(3): 426 - 434. [Abstract] [Full Text] [PDF]

				H. Echchannaoui, K. Frei, M. Letiembre, R. M. Strieter, Y. Adachi, and R. Landmann CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection J. Leukoc. Biol., September 1, 2005; 78(3): 705 - 715. [Abstract] [Full Text] [PDF]

				M. R.-E.-I. Benhnia, D. Wroblewski, M. N. Akhtar, R. A. Patel, W. Lavezzi, S. C. Gangloff, S. M. Goyert, M. J. Caimano, J. D. Radolf, and T. J. Sellati Signaling through CD14 Attenuates the Inflammatory Response to Borrelia burgdorferi, the Agent of Lyme Disease J. Immunol., February 1, 2005; 174(3): 1539 - 1548. [Abstract] [Full Text] [PDF]

				D. Heumann, R. Lauener, and B. Ryffel The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds Innate Immunity, December 1, 2003; 9(6): 381 - 384. [Abstract] [PDF]

				T. Pedron, C. Thibault, and P. J. Sansonetti The Invasive Phenotype of Shigella flexneri Directs a Distinct Gene Expression Pattern in the Human Intestinal Epithelial Cell Line Caco-2 J. Biol. Chem., September 5, 2003; 278(36): 33878 - 33886. [Abstract] [Full Text] [PDF]

				S. Tasaka, A. Ishizaka, W. Yamada, M. Shimizu, H. Koh, N. Hasegawa, Y. Adachi, and K. Yamaguchi Effect of CD14 Blockade on Endotoxin-Induced Acute Lung Injury in Mice Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 252 - 258. [Abstract] [Full Text] [PDF]

				H. F. Gomez, T. J. Ochoa, I. Herrera-Insua, L. G. Carlin, and T. G. Cleary Lactoferrin Protects Rabbits from Shigella flexneri-Induced Inflammatory Enteritis Infect. Immun., December 1, 2002; 70(12): 7050 - 7053. [Abstract] [Full Text] [PDF]

				H. d'Hauteville, S. Khan, D. J. Maskell, A. Kussak, A. Weintraub, J. Mathison, R. J. Ulevitch, N. Wuscher, C. Parsot, and P. J. Sansonetti Two msbB Genes Encoding Maximal Acylation of Lipid A Are Required for Invasive Shigella flexneri to Mediate Inflammatory Rupture and Destruction of the Intestinal Epithelium J. Immunol., May 15, 2002; 168(10): 5240 - 5251. [Abstract] [Full Text] [PDF]

				D. Heumann CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria Innate Immunity, December 1, 2001; 7(6): 439 - 441. [Abstract] [PDF]

				D. Le Roy, F. Di Padova, Y. Adachi, M. P. Glauser, T. Calandra, and D. Heumann Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria J. Immunol., September 1, 2001; 167(5): 2759 - 2765. [Abstract] [Full Text] [PDF]

				T. Axtelle and J. Pribble IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis Innate Immunity, August 1, 2001; 7(4): 310 - 314. [Abstract] [PDF]